Copyright © 1999 by the European Society of Cardiology.
Editorial
Metabolic treatment of myocardial ischaemia
a Editor, European Heart Journal Supplements
1999, 1999
References
- Boddeke E, Hugtenburg J, Jap W. New anti-ischaemic drugs: cytoprotective action with no primary haemodynamic effects. Trend Pharm Sci. 1981;10:340397[CrossRef]
- Stanley WC, Lopaschuk CD, Nail JL. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Cardiovasc Res. 1997;33:243257
[Free Full Text] - Detry JM, Seiller P, Pennafortes. Trimetazidine: a new concept in the treatment of angina. Comparison with propanolol in patients with stable angina. Br J Clin Pharmacol. 1994;37:279288[ISI][Medline]
- Manchanda SC, Krisimaswami S. Combination treatment with trimetazidine and diltiazem in stable angina pectoris. Heart. 1997;78:363367
- Michaelides AP, Spiropoulos K, Dimopoules K. Antianginal efficacy of the combination of trimetazidine-propanolol compared with isosorbide dinitrate-propanolol in patients with stable angina. Clin Drug Invest. 1997;13:814
This article has been cited by other articles:
![]() |
R. Ferrari Introduction Eur. Heart J. Suppl., November 1, 2001; 3(suppl_O): O1 - O1. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
